SUNNYVALE, Calif. - April 6, 2010 - Supply market volatility. Capacity constraints. Global uncertainty. They're the reality of doing business in the New Normal that all companies must deal with. Add to this calls for reform, regulatory uncertainty, competition from generic drugs, shrinking R&D pipelines and declining demand for elective procedures, and the reality becomes even more complex for healthcare concerns. On May 25, executives from top providers, producers, payers, and distributors will discuss these challenges and ways in which they can collaborate to overcome them during a Townhall Meeting at Ariba LIVE (www.aribalive.com), the premier conference for anyone engaged in buying, selling or managing cash, hosted by Ariba, Inc. (Nasdaq: ARBA), the leading spend management solutions provider. Click here for more.